The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.
BlackRock Sus Adg Intl Eq Inv A BRZAX
- NAV / 1-Day Return 11.76 / +0.26 %
- Total Assets 16.7 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.750%
- Distribution Fee Level Low
- Share Class Type Front Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 2.18%
- Turnover 118%
USD | NAV as of Jul 02, 2024 | 1-Day Return as of Jul 02, 2024, 10:10 PM GMT+0
Morningstar’s Analysis BRZAX
Will BRZAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 3.27 | 519,276 | Healthcare |
ASML Holding NV | 2.85 | 452,305 | Technology |
AstraZeneca PLC | 2.24 | 355,384 | Healthcare |
BlackRock Liquidity T-Fund Instl | 2.18 | 345,282 | Cash and Equivalents |
Novartis AG Registered Shares | 1.94 | 308,177 | Healthcare |
SAP SE | 1.86 | 294,496 | Technology |
Shell PLC | 1.85 | 293,855 | Energy |
Nestle SA | 1.67 | 264,391 | Consumer Defensive |
Siemens AG | 1.59 | 252,405 | Industrials |
Schneider Electric SE | 1.48 | 235,056 | Industrials |